Medication info
Risena Tablets (Risedronate Sodium 2.5 Hydrate)

Risena Tablets (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.2mg / 1 tablet
Manufacturer / importer
Korea PMG Pharmaceutical Co., Ltd.
Appearance
Yellow rectangular film-coated tablets
Packaging
4 tablets (4 tablets/PTP×1)
Approval status
Active

MFDS item code 200800315 · Notified 2008.01.08 · Insurance code 697100030

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Because food interferes with the absorption of this drug, take it at least 30 minutes before breakfast for adequate absorption, or at least 2 hours before or after consuming any food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it with an adequate amount of plain water (170 ∼ 230 mL) while in an upright position. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy of this drug in children under 18 years of age have not been established.

Ingredients

Manufacturer
Korea PMG Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and for the treatment of osteoporosis in men.

How to take

Adult dose

1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Because food interferes with the absorption of this drug, take it at least 30 minutes before breakfast for adequate absorption, or at least 2 hours before or after consuming any food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it with an adequate amount of plain water (170 ∼ 230 mL) while in an upright position. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this drug in children under 18 years of age have not been established.

Precautions

This medication may irritate the stomach and esophagus, so caution is especially needed for individuals with upper gastrointestinal diseases. It should be taken with a sufficient amount of water, and you must not lie down for at least 30 minutes after taking it. If you experience pain in the esophagus, difficulty swallowing, or heartburn, stop taking this medication immediately and consult a doctor. This medication should not be taken by individuals with esophageal disorders, hypocalcemia, severe kidney dysfunction, pregnant or breastfeeding women. As a bisphosphonate, long-term use can rarely lead to osteonecrosis of the jaw or atypical femur fractures, so caution is necessary. Calcium and vitamin D supplementation is required, and this medication should not be taken with medications or foods containing calcium, magnesium, or iron. To ensure the safety of children, keep this medication out of their reach, and do not transfer it to other containers. The safety and efficacy of this medication have not been established in children, and elderly patients can take it without special precautions. In case of overdose, calcium and phosphorus levels in the blood may decrease, so consult a healthcare provider immediately if symptoms appear.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • gastric ulcer
  • duodenal ulcer
  • infection
  • back pain
  • accidental injury
Show 55 more
  • pain
  • abdominal pain
  • flu symptoms
  • headache
  • weakness
  • pain in the neck area
  • chest pain
  • allergic reactions
  • hypertension
  • constipation
  • diarrhea
  • indigestion
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Riel syndrome
  • angioedema
  • skin reactions
  • external ear bone necrosis
  • iritis
  • uveitis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to keep air and moisture out. It is best to maintain a storage temperature between 1°C to 30°C. Proper storage will help ensure the medication's effectiveness.

Appearance and packaging

Appearance

Yellow rectangular film-coated tablets

Package unit

4 tablets (4 tablets/PTP×1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.